Podcasts about diagnostics

February 27, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: YOU(th) Health Tech raises $4.5M to expand smartphone-based health screening platform detecting 50+ digital biomarkers in under two minutes UFC Gym partners with NexGen MD Scientific to launch in-gym longevity clinics offering GLP-1s, peptides, and hormone replacement therapy XENOM raises $15M seed funding to launch "Decathlon of Fitness" with 10 standardized events, debuting at Dallas Cowboys facility in June More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden sits down in person with fitness and nutrition expert Autumn Calabrese to unpack the full truth about GLP-1 agonists. With millions of people jumping on semaglutide, tirzepatide, and soon retatrutide, the conversation most doctors aren't having is about what's actually happening inside the body while the scale goes down. Dr. Gladden breaks down how GLP-1s suppress hunger, slow metabolism, and trigger muscle wasting when used without proper diagnostics or a supporting protocol. He explains the critical differences between GLP-1s, GLP-2s, and GLP-3s, reveals why the ghrelin rebound causes most people to regain everything they lost, and shares the strategies he uses in his practice to help patients lose fat while protecting lean tissue. From the 5-day fasting mimicking diet to natural GLP-1 boosters like metabolic probiotics and calocurb, this episode lays out a smarter, more sustainable path to optimizing body composition. Whether you're considering a GLP-1, already on one, or looking for alternatives, this is the conversation that could change your entire approach. For Audience • Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!  • Subscribe to the Gladden Longevity Newsletter for the latest on longevity medicine, peptide protocols, and hormone optimization → https://start.gladdenlongevity.com/subscribe • Ready to find out what's really going on inside your body? Book a call with the Gladden Longevity team → https://start.gladdenlongevity.com/apply-now Takeaways • Peptides are signaling partners, not substitutes for the work your body needs to do.  • GLP-1s were designed for diabetics and metabolic syndrome, not casual weight loss. • GLP-1s decrease energy expenditure while GLP-3s (retatrutide) increase it. • Many GLP-1 users are losing muscle mass instead of fat without realizing it. • The ghrelin rebound after stopping a GLP-1 drives appetite higher than before while metabolism stays slower. • A fasting blood sugar and hemoglobin A1C alone are not enough to understand your metabolic health. • A two-hour glucose tolerance test with an insulin curve reveals insulin resistance most doctors completely miss. • The 5-day fasting mimicking diet resets ghrelin, taste buds, gut biome, and leptin sensitivity without destroying muscle. • You can boost your body's own natural GLP-1 production through the right probiotics and bitter receptor activation. • Weight gain is not always an appetite problem. Thyroid dysfunction, declining sex hormones, and missing micronutrients can all be the real driver. • Sex hormone optimization during perimenopause and andropause is critical for maintaining body composition. • Willpower never wins long term. Systems and environment design are what create durable results.    Chapters 00:00 Introduction and Welcome with Autumn 00:44 What Is a Peptide and How Peptides Work in the Body 03:07 BPC-157 and the Pharma Model vs. Peptide Signaling 05:00 You Can't Out-Peptide Bad Habits 06:31 What Is a GLP-1 and How It Affects Your Brain and Gut 08:57 GLP-1s Were Designed for Diabetics Not Weight Loss 09:40 GLP-2 Tirzepatide and GLP-3 Retatrutide Explained 11:00 Why Retatrutide Increases Energy Expenditure While GLP-1s Decrease It 12:00 The Muscle Mass Crisis on GLP-1s 14:06 The Patient Who Lost 20 Pounds of Pure Muscle 15:00 Protecting Muscle with Perfect Aminos and Creatine 17:00 Autumn's Personal Supplement Stack for Training 19:00 Food Noise Ghrelin and the Appetite Rebound 21:18 The 5-Day Fasting Mimicking Diet as a Metabolic Reset 23:00 Building Your Own Natural GLP-1 Production 25:00 The Glucose Tolerance Test Most Doctors Never Run 28:30 Risks of GLP-1s Pancreatitis Thyroid Tumors and Unsupervised Use 29:50 Microdosing GLP-1s in Perimenopause 30:30 Calocurb the Natural Appetite Suppressant from Hops 32:00 Sex Hormone Optimization for Body Composition 35:00 Resting Metabolic Rate Testing and Hidden Thyroid Dysfunction 38:00 Autumn's Hormone Health Program and Real Results 39:30 Willpower vs Systems and Architecting Your Environment 41:30 Bio-Individuality and Why Someone Else's Plan Won't Work for You 43:00 The Power of Diagnostics and Understanding Your Genetics  To learn more about Autumn: Instagram: @autumncalabrese Reach out to us at: Facebook: https://www.facebook.com/Gladdenlongevity/ Instagram: https://www.instagram.com/gladdenlongevity/?hl=en LinkedIn: https://www.linkedin.com/company/gladdenlongevity YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw   Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

When bacterial pneumonia in a dog or cat is treated and managed appropriately, the prognosis for most patients is good. This episode of the VetFolio Voice podcast reviews common causes of bacterial pneumonia in dogs and cats, including aspiration and infectious causes. Dr. Cassi and Dr. Lori Waddell discuss the importance of the patient's signalment and history in assessing risk factors for the various causes of pneumonia. Diagnostics, including thoracic radiographs and airway sampling–its usefulness and indications—as well as choosing empirical antibiotic therapy are also explored.

Certaines malformations du pied sont congénitales, c'est-à-dire qu'elles sont présentes à la naissance. C'est le cas par exemple du pied-bot, qui touche un à deux bébés sur 1 000 naissances. D'autres malformations et déformations du pied peuvent survenir au fil des ans. Les pieds étant particulièrement sollicités tout au long de la vie, ils peuvent subir des déformations des orteils (cor, durillon) ou de la voûte plantaire. Ces déformations du pied peuvent donc être provoquées par de multiples causes, quels sont les principaux diagnostics ? Pourquoi certaines de ces atteintes ont-elles un caractère héréditaire ?  Avec : Dr Christophe Piat, Chirurgien orthopédiste et traumatologue à la clinique Victor Hugo, à Paris et ancien chirurgien des hôpitaux de Paris À lire aussiMalformations et déformations des pieds

In this episode of the Health Coach Academy Podcast, we sit down with Maeve Ferguson, former Big Four consultant turned online business strategist, to unpack one of the most underrated but powerful marketing tools in the coaching industry: diagnostic quizzes and score-based assessments. Maeve shares how health coaches, consultants, and experts can transform their intellectual property into scalable lead-qualification systems that attract high-quality, high-ticket clients — without wasting hours on unqualified discovery calls. If you've ever wondered how quizzes actually work behind the scenes — or why some coaches quietly scale to multi-six-figure and seven-figure businesses — this episode pulls back the curtain.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how collaborations are helping drive transformation in clinical diagnostics. Together, they explore:Protecting Access to Medicare Act (PAMA) delay (01:09): Dr. Morice shares what the latest delay of PAMA means for laboratories.FDA guidance on wearables (02:23): Learn about recent FDA guidance that allows more non‑invasive wearables to be classified as wellness devices. Collaboration as a driver of innovation (06:20): Discover why collaboration is critical to advancement in clinical diagnostics.Note: Information in this post was accurate at the time of its posting.ResourcesGroundbreaking collaborationsMary Jo Williamson offers four steps to maximize collaboration benefitsDr. Bill Morice shares how a platform for collaboration transforms diagnostics“Answers From the Lab” podcast: “Forging Collaborations That Deliver Better Outcomes”

This episode examines how diagnostic tools and imaging for microvascular dysfunction are evolving, the paradox of 'clear' arteries in symptomatic women, and barriers to broader implementation in clinical practice. Timestamps: 00:45 – Angina in women 03:43 – Defining ischaemia 05:35 – Barriers to microvascular testing

February 17, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: YC-backed Fort opens pre-orders for strength-specific wearable that auto-detects exercises, reps, sets, and fatigue without manual logging Stanford-born Clair develops wrist-worn device using 10 biosensors and AI to estimate real-time hormone levels including estrogen and progesterone, shipping in November Matrix Bio claims to have built five-minute, $5 multi-marker hormone test requiring no lab or blood draw, pending clinical regulatory validation I'm heading to LA this week for the Connected Health & Fitness Summit to host a fireside chat with Fritz Lanman, CEO of Playlist (parent company of Mindbody and ClassPass), on AI in fitness and the anticipated $7.5B EGYM merger. If you're attending or based in LA and want to meet up, email team@fitt.co. More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co  

In today's VETgirl online veterinary continuing education podcast, we're talking about feline infectious peritonitis (FIP)! In the last few years, antivirals have completely flipped the script on what used to be a largely fatal disease - reported response rates are climbing! As we scramble to give these cats a fighting chance with evolving antiviral protocols, clinicians around the world are sharing what's working - and what isn't - and that collective experience is sharpening both our diagnostic workups and our treatment plans. Tune in to hear what we have learned about FIP diagnostics as we head into 2026.

In today's VETgirl online veterinary continuing education podcast, we're talking about feline infectious peritonitis (FIP)! In the last few years, antivirals have completely flipped the script on what used to be a largely fatal disease - reported response rates are climbing! As we scramble to give these cats a fighting chance with evolving antiviral protocols, clinicians around the world are sharing what's working - and what isn't - and that collective experience is sharpening both our diagnostic workups and our treatment plans. Tune in to hear what we have learned about FIP diagnostics as we head into 2026.

Arthur MacWaters, CEO of Legions Health, joins the program for a timely and necessary conversation on the future of artificial intelligence in healthcare. AI is rapidly reshaping medicine, diagnostics, and personal health—but where does it truly lead? In this episode, we explore what's genuinely possible, what's already happening, and where the real risks lie. MacWaters breaks down the good, the bad, and everything in between: how AI can be used to restore health, prevent disease, and empower individuals—and how the same tools can just as easily be weaponized for control, profit, surveillance, and centralized power at the expense of human well-being. If AI is going to define the next era of healthcare, the question is no longer whether it will be used—but who it will ultimately serve.Follow MacWaters on X@ArthurMacwatersSee exclusives at https://SarahWestall.Substack.com

• Support & get perks!• Proudly sponsored by PyMC Labs! Get in touch at alex.andorra@pymc-labs.com• Intro to Bayes and Advanced Regression courses (first 2 lessons free)Our theme music is « Good Bayesian », by Baba Brinkman (feat MC Lars and Mega Ran). Check out his awesome work !Chapters:00:00 Exploring Generative AI and Scientific Modeling10:27 Understanding Simulation-Based Inference (SBI) and Its Applications15:59 Diffusion Models in Simulation-Based Inference19:22 Live Coding Session: Implementing Baseflow for SBI34:39 Analyzing Results and Diagnostics in Simulation-Based Inference46:18 Hierarchical Models and Amortized Bayesian Inference48:14 Understanding Simulation-Based Inference (SBI) and Its Importance49:14 Diving into Diffusion Models: Basics and Mechanisms50:38 Forward and Backward Processes in Diffusion Models53:03 Learning the Score: Training Diffusion Models54:57 Inference with Diffusion Models: The Reverse Process57:36 Exploring Variants: Flow Matching and Consistency Models01:01:43 Benchmarking Different Models for Simulation-Based Inference01:06:41 Hierarchical Models and Their Applications in Inference01:14:25 Intervening in the Inference Process: Adding Constraints01:25:35 Summary of Key Concepts and Future DirectionsThank you to my Patrons for making this episode possible!Links from the show:- Come meet Alex at the Field of Play Conference in Manchester, UK, March 27, 2026!- Jonas's Diffusion for SBI Tutorial & Review (Paper & Code)- The BayesFlow Library- Jonas on LinkedIn- Jonas on GitHub- Further reading for more mathematical details: Holderrieth & Erives- 150 Fast Bayesian Deep Learning, with David Rügamer, Emanuel Sommer & Jakob Robnik- 107 Amortized Bayesian Inference with Deep Neural Networks, with Marvin Schmitt

In this episode of Disruption/Interruption, KJ sits down with Julian Circo, Co-Founder of Hyfe, a company revolutionizing respiratory health diagnostics through AI-powered cough monitoring. Julian shares his unconventional journey from humanitarian work in post-conflict zones to building the world's largest cough dataset—over 700 million samples. The conversation explores how Hyfe is transforming coughing from a subjective symptom into an objective, quantifiable biomarker, enabling better research, drug development, and patient care. Julian discusses the challenges of disrupting the conservative pharmaceutical industry, the surprising complexity of measuring coughs, and Hyfe's groundbreaking digital therapeutic for chronic cough sufferers. Four Key Takeaways [0:41] Coughing is Medicine's Most Common Yet Least Understood Symptom - Despite being the single most common symptom in medicine for over a century, medical science still cannot answer basic questions like "what is a normal amount of coughing for a healthy person?" Even top pulmonologists disagree significantly on this fundamental question. [11:27] Building the World's Largest Cough Dataset Required Creative Problem-Solving - Hyfe collected over 700 million cough samples by launching a free consumer app during COVID-19 that monitored coughs in the background. This approach solved the critical challenge of gathering diverse, real-world data across different demographics, environments, and microphones—essential for training accurate AI models. [21:52] Pharma's Resistance to Disruption is Actually Rational - The pharmaceutical industry's notorious resistance to innovation stems from legitimate needs: trials spanning months or years require consistent measurement methods to compare data over time. Hyfe succeeded by "leading with science" rather than pitching disruption, focusing on the measurable value they create. [27:30] A Digital Therapeutic Offers Hope Where 15 Drug Trials Failed - Over the past 13 years, 15 pharmaceutical molecules for chronic cough treatment have failed clinical trials. Hyfe is developing a digital therapeutic based on behavioral cough suppression therapy—similar to physical therapy for joints—that has already shown 40% efficacy in preliminary research, offering hope to the one in ten Americans suffering from chronic cough. Quote of the Show (4:28):"People innovate as a way of life. It’s not a luxury. You have to find ways to communicate. You have to find ways to access goods. You have to find ways to make do…” – Julian Circo Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Julian Circo: LinkedIn: https://www.linkedin.com/in/icirco/Company Website: https://www.hyfe.com/Failed Chronic Cough Candidates: https://support.hyfe.com/hubfs/HTML/failed_antitussives_timeline.htmlCoughPro: https://coughpro.com/ How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

This episode features a highlighted segment from the ROI Centered Care Virtual Summit, produced by Bright Spots Ventures in partnership with TytoCare and the American Telemedicine Association. In this conversation, Eric Glazer sits down with Fernando Carnavali, MD, Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Chief of General Internal Medicine at Mount Sinai Health System, to explore how large academic health systems can translate patient experience, diagnostics, and technology innovation into measurable ROI. Rather than focusing on new tools for their own sake, Dr. Carnavali reframes the challenge: how to use existing data, connected devices, and AI-enabled diagnostics to improve the full patient journey, before, during, and after the visit while also supporting a stretched clinical workforce. Drawing on Mount Sinai's real-world operating environment, the conversation explores how experience, communication, and clinical efficiency are increasingly inseparable from financial performance, especially in inpatient and general internal medicine settings. This discussion moves beyond pilot thinking to address what it takes to operationalize innovation at scale inside a complex health system. What you'll learn in this episode: Why patient experience is a longitudinal journey, not a post-visit survey score How Mount Sinai is using technology and diagnostics to strengthen communication, not replace clinicians The role of AI and connected devices in improving both patient and provider experience Why workforce constraints in primary and general internal medicine demand new care models How health systems can focus on what's already within their control to drive ROI Why proving clinical and economic value upfront is essential to scaling innovation About Dr. Fernando Carnavali: Dr. Carnavali is the Chief of the Division of General Internal Medicine for Mount Sinai Morningside and Mount Sinai West (MSM/MSW) and serves as the Medical Director of the Long COVID Satellite Clinic at Mount Sinai Doctors Ansonia (MSD-Ansonia). In this role, Dr. Carnavali oversees a large, complex division with eight outpatient service locations spanning Manhattan's West Side from Harlem to Chelsea. Clinically, he focuses on the treatment and management of chronic illness, with a particular emphasis on Long COVID care. In early 2020, Dr. Carnavali led MSM/MSW's outpatient response to the COVID-19 pandemic, organizing early testing and triage for community patients and serving for eight weeks on the inpatient COVID units—an experience that provided firsthand insight into the impact of SARS-CoV-2 in New York City. In May 2021, he coordinated the launch of the Long COVID Clinic at MSD Ansonia and continues to personally evaluate new and ongoing patients each week. Committed to sharing Mount Sinai's expertise in Long COVID care, Dr. Carnavali has participated in numerous national and international forums, training providers in this emerging field. He has also built a strong media presence, spotlighting both the Ansonia clinic and the Mount Sinai Long COVID program to raise public awareness. Since 2024, he has served as Co-Principal Investigator on a grant from the Agency for Healthcare Research and Quality (AHRQ) and the Department of Health and Human Services titled "Evaluation of Long COVID Care Practices." In addition to Long COVID work, Dr. Carnavali leads outpatient practice transformation initiatives across MSM/MSW and the Mount Sinai Health System, guiding quality improvement teams to enhance patient satisfaction, improve access to care, and explore innovative service models.   Podcast Recommendation: Check out Access Amplified, brought to you by TytoCare and hosted by Joanna Braunold - a podcast about how digital health is helping increase access to care and equity, one innovation at a time. We'll shine a light on what's actually working to make care more accessible and  inclusive. If you're a healthcare leader, an innovator, a policy shaper, or anyone passionate about health equity, this podcast is for you. New episodes drop every two weeks. Follow or subscribe wherever you get your podcasts. https://www.tytocare.com/resources/access-amplified Thank You to Our Episode Partner, TytoCare. TytoCare enables health systems and plans to deliver high-quality remote exams anytime, anywhere. Their FDA-cleared devices and AI-powered diagnostic platform support virtual specialty care, school-based programs, and home health models—reducing unnecessary ED visits and improving patient experience. To learn more, visit tytocare.com. Schedule a Meeting with a Senior Leader at TytoCare: To explore how TytoCare can help your organization expand virtual specialty access and improve care coordination, reach out to jtenzer@brightspotsventures.com  to schedule a meeting. About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare, proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.  

In this episode of the Tails From the Lab podcast, co-host Dr. Brad Ryan sits down with Dr. Michelle Evason (BSc, DVM, DACVIM, MRCVS), Director of Veterinary Education & Outreach at Antech and MARS Science and Diagnostics. Dive into the fascinating world of gastrointestinal parasites with Dr. Evason, a leading expert and educator in small animal internal medicine, infectious disease, and One Health. Discover how data from millions of fecal PCR tests are transforming veterinary clinical decision-making, revealing emerging multidrug parasite resistance, and reshaping our understanding of One Health risks that impact pets, people, and wildlife alike. From the importance of One Health and zoonotic concern messaging to the nuances of fecal screening in cats and dogs, listen in for more about: The power of collaboration and data sharing in veterinary parasitology Landmark cases of Echinococcus multilocularis in the US and Canada The rise of hookworm drug resistance and what it means for treatment Broader trends affecting parasite prevalence, including climate change and pet travel Practical advice for veterinarians on fecal testing and antimicrobial stewardship Future directions in parasite research and diagnosticsOur guest today is Dr. Michelle Evason who is employed by Antech. We're sharing this so you have full transparency about the relationships involved. Tails From the Lab is a production of Antech Diagnostics. The intent of this podcast is to provide education and guidance with the understanding that any diagnostic testing and treatment decisions are ultimately at the discretion of the attending veterinarian within the established veterinarian-patient-client relationship.

Cardiac Symptoms & Diagnostics: A Practical Guide for Primary Care Evaluation and Credit:  https://www.surveymonkey.com/r/medchat87 Target Audience This activity is targeted toward primary care physicians and advanced providers. Statement of Need This podcast will provide tools for clinicians to interpret cardiac symptoms accurate, utilize the right diagnostic tools resulting in early detection and improved management of cardiovascular disease. Objectives Discuss evidence-based criteria to determine when specific cardiology diagnostic tests are indicated.  Describe red flags that warrant urgent testing or specialty referral Differentiate between cardiac diagnostic testing and clinical indications. Moderator Monalisa Tailor, M.D. Internist Norton Community Medical Associates - Barret Louisville, KY Speaker Mostafa O. El – Refai, M.D., M.Sc., MBA Interventional Cardiologist Norton Heart and Vascular Institute Louisville, KY Medical Director, Norton Brownsboro Hospital System Medical Director for Quality Norton Healthcare Louisville, KY Planners, Moderator and Speaker Disclosure  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose. Commercial Support There was no commercial support for this activity.  Physician Credits Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.   For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.   Resources for Additional Study/References Mesa CA Score Calculator https://ebmcalc.com/NoteRight3000/MESA.htm National Heart, Lung and Blood Institute – Coronary Heart Disease Diagnosis https://www.nhlbi.nih.gov/health/coronary-heart-disease/diagnosis Cardiovascular Risk Assessment: Practical Tips for the Internal Medicine Specialist https://pubmed.ncbi.nlm.nih.gov/41285656/   Date of Original Release | Feb. 2026; Information is current as of the time of recording. Course Termination Date | Feb. 2029 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

Most service calls don't fail during diagnostics. They fail in the moment after. The inspection is complete. The findings are clear. And then the conversation stalls. In this episode of Windshield Time, we break down why service calls stall after diagnostics and what technicians can do to move the call forward without sounding salesy, awkward, or unsure. This isn't about closing harder. It's about leading the next step. In this episode, you'll learn: Why technicians hesitate after diagnostics The difference between findings and forward motion How hesitation weakens confidence and trust Why customers feel uncertainty in the pause The mistake techs make when they over-explain How clear options move the call forward naturally Why structure beats persuasion What to do immediately after diagnostics are complete If you've ever finished an inspection and thought, "Now what?", this episode shows you exactly what's missing.

In this episode, host Don Adeesha sits down with Sonja Landtrachtinger, CEO of Beauty Zentrum Group, to address the frustration of the "non-responder" - the patient who undergoes treatments but fails to see results. Sonja argues that clinics typically blame the device when they should be blaming the biology, specifically the gut-skin connection. She details her business model based on neuroaesthetics, where she treats the nervous system, gut microbiome, and microcirculation to resolve internal bottlenecks before attempting to fix external beauty. Sonja breaks down her "Skin Proof Method," a system that combines AI skin analysis with dried blood microbiome testing to generate hyper-personalized treatment plans. She explains how this data-driven approach operationalizes the sales process, empowering her staff to sell complex, invisible treatments without feeling "pushy" because the AI provides the prescription. This rigorous diagnostic process allows her to offer a money-back guarantee on results - a rarity in the industry - while commanding prices between €800 and €2,500 for six-month transformation packages. Finally, Sonja explores the rising phenomenon of "Cortisol Face," explaining how chronic stress physically blocks aesthetic efficacy and how her clinic uses sensory cues like sound and lighting to shift patients out of fight-or-flight mode. She advocates for "Honest Aesthetics," sharing why she refuses service to clients seeking unrealistic, filter-based results, and urges clinic owners to trust their gut instinct to innovate, even when the industry says it cannot be done.

In this episode of Marni On The Move, I'm joined by Dr. Michael Doney, Executive Medical Director at Biograph, for a conversation on the future of proactive, personalized healthcare and a deep dive into diagnositcs. Biograph is delivering one of the most advanced approaches to preventive care—combining comprehensive health assessments, deep diagnostics, and expert-led support to help individuals translate complex data into meaningful, actionable insights. We explore how this model shifts healthcare from reactive treatment to long-term health optimization, and why foundational health practices matter for everyone—from everyday individuals to high-performing athletes. Topics We Discuss: An introduction to Biograph and its mission Comprehensive health assessments and diagnostic tools Who Biograph serves: understanding its client demographics The importance of proactive and preventive healthcare The Biograph method: from data to action The membership model and overall client experience Performance optimization for athletes The “athlete paradox” and long-term health considerations The transformative impact of preventive healthcare The role of AI and advanced diagnostics Future innovation at Biograph and emerging diagnostic technologies Foundational health practices that support long-term health for everyone CONNECT Biograph on Instagram Marni On The Move Instagram, TikTok, LinkedIn, or YouTube` Marni Salup on Instagram and Playlist on Spotify SUBSCRIBE TO OUR NEWSLETTER Sign up for our monthly newsletter, Do What Moves You, for Marni on the Move updates, exclusive offers, invites to events, and exciting news! SUPPORT THE PODCAST Leave us a five stars and a review on Apple, it’s easy, scroll through the episode list on your podcast app, click on five stars, click on leave a review, and share what you love about the conversations you’re listening to. Tell your friends the episodes you are listening to on your social. Share a screen shot of the episode in your stories, tag us, we will tag you back!

We are in Week 3 of our 4-part series on Cancer, the #2 killer in America.   Early diagnostics have helped reduce the death rate from Cancer.  In this episode, you'll discover:—Why Dr. Prather says that diagnostics are even more important in the Structure-Function Health Care than in Disease Care.—The story of the oncologists who are surprised at how early Holistic Integration is able to detect certain types of Cancer that are usually not found until they are far more developed. —How Dr. Prather has over 600 hours of studying bloodwork, while the typical Medical Doctor has 15 hours of study in their education.—Why Liver Enzymes are so important in Cancer Diagnostics.  And how Dr. Prather says keeping those levels where they should be actually helps patients to be able to complete their Chemotherapy and Radiation treatments. —The reason Dr. Prather does not recommend Coffee Enemas and instead offers his patients a safer and more gentle form of detoxification. —The astonishingly low percentage of patients who first come into Holistic Integration who have the right lab test values for their Liver and their Immune system.—Why tumor markers are important in Cancer diagnostics and in evaluating care.  And why Dr. Prather tests for these more often than most Oncologists do. —The importance of Hair Analysis to determine Heavy Metals in the body that can lead to Cancer.  And the worst toxin for Cancer, which was found in Agent Orange and passed onto the daughters of Vietnam Veterans who were exposed to it. —How 80% of the immune system is found in the gut, which is best tested through a stool kit.  And the stories of Cancer patients who were helped because of the toxins, parasites, and infections detected in their stool kit. —The Micronutrients blood test that Dr. Prather recommends to all of his Cancer patients, which can help both in the prevention of Cancer and increasing someone's odds of surviving it.http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

Broadcast from KSQD, Santa Cruz on 1-29-2026: An emailer asks about hemorrhoids affecting 2 relatives,a 60-year-old man and his 20-year-old daughter, with the daughter also experiencing constipation worsened by fiber supplements. Dr. Dawn explains hemorrhoids are essentially varicose veins of the anus, with 102 genetic regions identified affecting blood vessel and smooth muscle strength. She emphasizes that fiber supplements without adequate water create "cement in the pipe"—recommending 16-24 ounces of water with supplements and 2 liters of clear water daily. Miralax also requires sufficient hydration to work. Key strategies include exercise to stimulate gut motility, staying off the toilet if unable to produce results, using a standing desk to reduce prolonged sitting pressure, and triggering the gastrocolic reflex by eating. Dr. Dawn discusses research on the "volatilome"—volatile organic compounds in breath that reflect gut microbiome composition. Researchers using sterile mice colonized with specific bacteria could identify bacterial fingerprints through breath analysis. The technique identified disease-associated compounds for tuberculosis and malaria, and correlated specific gut bacteria with asthma severity in children. The research suggests breath testing could eventually replace stool samples for microbiome assessment and disease screening. She explains detoxification biochemistry, distinguishing between water-soluble toxins easily filtered by kidneys and fat-soluble toxins requiring liver transformation. Phase one converts fat-soluble molecules into reactive intermediates—dangerous if they linger—while phase two attaches water-soluble molecules like glutathione to neutralize them for excretion. Supporting phase two requires green tea, cruciferous vegetables, garlic, and curcumin. She cautions against extended fasting for detox, especially over age 50, as it depletes the body's detoxification resources and muscle mass. A caller asks about alkaline versus acidic water. Dr. Dawn explains you cannot alkalinize blood since kidneys maintain pH, but alkaline urine is beneficial. Rather than expensive alkaline waters, adding a pinch of baking soda achieves the same effect. Eating a 3:1 ratio of fruits, vegetables, and grains to animal products naturally alkalinizes urine. She notes lemons paradoxically alkalinize because kidneys overcompensate for the acid load. A caller asks about managing heart disease after receiving a third stent. Dr. Dawn recommends the Mediterranean diet over DASH for cardiac patients, as Mediterranean emphasizes fish, whole grains, and fiber that binds cholesterol for excretion, while DASH focuses on calcium for hypertension. She encourages exploring exercise options through meetup.com groups and the hospital's lifestyle center, emphasizing that consistent effort can reduce biological age by 3-5 years regardless of chronological age.

Dr. Marc Hedrick, President and CEO of Plus Therapeutics Inc.,  has expanded their focus from glioblastoma to leptomeningeal metastasis, a central nervous system cancer that is a growing challenge due to increased survival rates from primary cancers. Their highly sensitive, advanced diagnostic test, CNSide, can detect cancer cells in cerebrospinal fluid, addressing the shortcomings of imaging and outdated standard-of-care practices. Using AI and advanced data analytics, their lead drug candidate is uniquely suited for treating CNS cancers because its safety at high doses enables the precise delivery of radiation. Marc explains, "Since we last talked and we discussed primarily the use of radiotherapeutics for the treatment of glioblastoma. We've expanded that pretty significantly into a disease called leptomeningeal metastasis. And I think we may have touched on that briefly, at least conceptually, a few years ago. But now it's really real. We've just completed a phase one trial, and we're expanding that with the goal of getting the drug approved, perhaps sooner than with glioblastoma, by focusing on leptomeningeal cancer, for which there's nothing approved. And maybe it would be a good idea to back up and explain a little bit about what that is, because there's an epidemic of it that's not commonly understood."   "So the central nervous system is a protected organ in the body. Now, I mean the brain and the spinal cord. And it's that way for a reason to keep bad things out. Things like infections, tumors, or certain chemical toxins. And that includes drugs. Only about 2% of all drugs get into the central nervous system, which is a problem from a therapeutic perspective. But there's an epidemic in terms of metastases to the brain and spinal cord. Let's call those the CNS collectively. And that's because many common tumors like breast cancer, lung cancer, gastrointestinal cancers, and melanoma are better controlled locally with drugs that don't have to worry about getting into the central nervous system. They just need to get into those specific organs and tissues and then exert control over the tumor where it occurred."    $PSTV #LM #CNS #Cancer #LeptomeningealMetastases #CNSide #BrainCancer #Oncology #Radiotherapeutics #MedicalInnovation #CancerResearch #Biotechnology #PatientCare #ClinicalTrials #HealthcareInnovation #CancerTreatment #Neuroscience #MedTech plustherapeutics.com Listen to the podcast here

Dr. Marc Hedrick, President and CEO of Plus Therapeutics Inc.,  has expanded their focus from glioblastoma to leptomeningeal metastasis, a central nervous system cancer that is a growing challenge due to increased survival rates from primary cancers. Their highly sensitive, advanced diagnostic test, CNSide, can detect cancer cells in cerebrospinal fluid, addressing the shortcomings of imaging and outdated standard-of-care practices. Using AI and advanced data analytics, their lead drug candidate is uniquely suited for treating CNS cancers because its safety at high doses enables the precise delivery of radiation. Marc explains, "Since we last talked and we discussed primarily the use of radiotherapeutics for the treatment of glioblastoma. We've expanded that pretty significantly into a disease called leptomeningeal metastasis. And I think we may have touched on that briefly, at least conceptually, a few years ago. But now it's really real. We've just completed a phase one trial, and we're expanding that with the goal of getting the drug approved, perhaps sooner than with glioblastoma, by focusing on leptomeningeal cancer, for which there's nothing approved. And maybe it would be a good idea to back up and explain a little bit about what that is, because there's an epidemic of it that's not commonly understood."   "So the central nervous system is a protected organ in the body. Now, I mean the brain and the spinal cord. And it's that way for a reason to keep bad things out. Things like infections, tumors, or certain chemical toxins. And that includes drugs. Only about 2% of all drugs get into the central nervous system, which is a problem from a therapeutic perspective. But there's an epidemic in terms of metastases to the brain and spinal cord. Let's call those the CNS collectively. And that's because many common tumors like breast cancer, lung cancer, gastrointestinal cancers, and melanoma are better controlled locally with drugs that don't have to worry about getting into the central nervous system. They just need to get into those specific organs and tissues and then exert control over the tumor where it occurred."    $PSTV #LM #CNS #Cancer #LeptomeningealMetastases #CNSide #BrainCancer #Oncology #Radiotherapeutics #MedicalInnovation #CancerResearch #Biotechnology #PatientCare #ClinicalTrials #HealthcareInnovation #CancerTreatment #Neuroscience #MedTech plustherapeutics.com Download the transcript here

Andrew Jacques, Giuliano Testa, Massimo Mangiola, Liza Johannesson. Uterus Transplantation—Current Evaluation, Monitoring, and Emerging Diagnostics. Clinical Chemistry, Volume 72, Issue 1, January 2026, Pages 18–26. https://doi.org/10.1093/clinchem/hvaf143

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Lisa Mosconi is a world-renowned neuroscientist and the director of the Women's Brain Initiative at Weill Cornell Medicine, where she studies how sex differences and hormonal transitions influence brain aging and Alzheimer's disease risk. In this episode, Lisa explores why Alzheimer's disease disproportionately affects women and why longer lifespan alone does not explain their nearly twofold risk compared to men. She explains why Alzheimer's disease may be best understood as a midlife disease for women, beginning decades before symptoms appear, and how menopause represents a fundamental brain event that reshapes brain energy use, structure, and immune signaling. The conversation also examines what advanced brain imaging reveals about preclinical Alzheimer's disease, estrogen receptors in the brain, and why genetic risks such as APOE4 appear to affect women differently from men. Finally, Lisa discusses the nuanced evidence around menopause hormone therapy, the legacy of the WHI, her new CARE Initiative to cut women's Alzheimer's risk in half by 2050, and practical, evidence-based strategies to support brain health through midlife—including lifestyle, sleep, metabolism, mood, and emerging therapies such as GLP-1 agonists and SERMs (selective estrogen receptor modulators). We discuss: How Lisa's personal family history and scientific background led her to focus on the intersection of women's health, brain aging, and Alzheimer's disease (AD) [2:45]; The long preclinical phase of AD and the emotional burden carried by patients before dementia becomes severe [7:15]; How AD compares to other common forms of dementia: prevalence, pathology, symptoms, diagnostic challenges, and more [10:45]; Why AD disproportionately affects women: how AD is not simply a disease of old age or longevity but a midlife disease in which women develop pathology earlier [16:15]; Menopause as a leading explanation for women's increased Alzheimer's risk, and how advanced braining imaging can detect early changes in the brain [26:15]; How a new method for imaging estrogen receptors in the brain is changing how we think about the menopause transition [35:45]; What estrogen receptor imaging can and cannot tell us about hormone therapy's potential impact on brain health [48:45]; Lisa's studies on the relationship between levels of systemic estrogen and density of estrogen receptors in the brain [58:00]; Why blood estrogen levels poorly reflect brain estrogen signaling, and how tightly regulated brain hormone dynamics complicate our understanding of menstrual-cycle and lifestyle effects [1:02:15]; The CARE Initiative: Lisa's research program looking to slash AD rates in women [1:07:45]; The dramatic difference in AD risk between men and women associated with APOE4 [1:10:45]; What the evidence suggests about menopausal hormone therapy (MHT) and AD risk, and why timing, formulation, and uterine status appear to matter [1:12:00]; How the CARE initiative plans to study MHT and AD risk, within the practical constraints of a three-year research window [1:17:30]; How to think about starting hormone therapy during perimenopause: balancing symptom relief, hormonal variability, and individualized care [1:21:00]; Investigating selective estrogen receptor modulators (SERMs) as a targeted approach to brain health during and after menopause [1:25:00]; Why estrogen became wrongly associated with cancer risk and what the evidence actually shows [1:29:30]; Why better biomarkers are central to advancing women's Alzheimer's research [1:38:30]; Modifiable risk factors for dementia, the limitations of risk models, and questionable conclusions drawn from observational data [1:44:15]; GLP-1 agonists and brain health: exploring potential neuroprotective effects of GLP-1 agonists beyond metabolic benefits [1:49:00]; The importance of lifestyle factors in reducing risk of dementia: practical strategies for women to support brain health [1:53:45]; Why long-term, consistent lifestyle habits are essential for building cognitive resilience and protecting brain health over decades [2:01:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Tick-borne diseases continue to expand across North America, but diagnosing them in the clinical laboratory remains complex—especially when timing between symptom onset and testing isn't considered. In this episode of Let's Talk Micro, Luis is joined by Kyle Rodino, Assistant Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Assistant Director of Microbiology, for a lab-focused discussion on tick-borne disease diagnostics. They cover major bacterial, parasitic, and viral causes of tick-borne disease, and walk through how molecular testing, serology, and microscopy are used at different stages of illness. The conversation highlights why test selection and timing matter, common diagnostic challenges—particularly with Babesia and Lyme disease testing—and how laboratories can support better diagnostic decision-making. A practical episode for microbiologists, laboratorians, and clinicians navigating real-world testing challenges in the lab.   Additional resources: Update on North American tick-borne diseases and how to diagnose them https://doi.org/10.1128/jcm.00807-23   Stay connected with Let's Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at letstalkmicro@outlook.com Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8   Support the podcast: Venmo Buy me a Ko-fi  

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Eugene: Staying focused on a North Star.Eugene Chan, CEO and founder of rHEALTH, has taken blood diagnostics to new heights—literally. His innovative technology, capable of analyzing dozens of biomarkers from a single drop of blood, was tested aboard the International Space Station (ISS). In today's episode, Eugene shared the remarkable journey of rHEALTH, from competing with top companies for a NASA partnership to launching its device into space.What sets rHEALTH apart is its proven reliability in extreme conditions, including the zero-gravity environment of space. Eugene explained, “We tested this technology on the International Space Station with astronaut Samantha Cristoforetti, who operated the device and obtained precise values from single drops of sample. They did the analysis using our device and got absolutely the right answers.” This achievement underlines the robustness and accuracy of rHEALTH's technology, qualities that distinguish it from other attempts at single-drop blood diagnostics.Unlike Theranos, which famously failed to deliver on similar promises, rHEALTH's technology has been rigorously vetted. Eugene highlighted the grueling process of earning NASA's trust. “To be the one company selected to demonstrate our novel technology on the ISS was a huge undertaking,” he said. He recounted the intense competition and NASA's exacting standards, which included testing the device's functionality during zero-gravity parabolic flights.Now, Eugene and his team are bringing this groundbreaking technology to the public with a regulated crowdfunding campaign on StartEngine. “You don't have to be a Silicon Valley elite or a Boston venture capitalist to participate,” I noted during the episode. With this campaign, everyday investors have the opportunity to support a proven technology poised to revolutionize healthcare.The implications of rHEALTH's success are profound. If it works in space, it can work in remote clinics, underserved communities, and even in people's homes. This technology has the potential to make diagnostics more accessible, empowering individuals to take control of their health.Eugene's vision, combined with rHEALTH's proven track record, makes this an exciting investment opportunity. Visit StartEngine to learn more and become part of this revolutionary journey.tl;dr:Eugene Chan shared how rHEALTH's diagnostic technology was tested and proven aboard the International Space Station.He explained the rigorous process of competing with other companies to secure NASA's trust.rHEALTH's crowdfunding campaign on StartEngine makes investing in this revolutionary technology accessible to all.Eugene highlighted the importance of his North Star: improving human health with innovative solutions.He shared advice on maintaining focus and using challenges as opportunities to achieve big goals.How to Develop Staying Focused on a North Star As a SuperpowerEugene's superpower is his ability to maintain a relentless focus on his “North Star”—the overarching goal of improving human health. As he explained, “The North Star has always been to improve the human condition and help us improve human health.” For Eugene, this guiding principle has driven his work through challenges, from competing for NASA's attention to developing groundbreaking diagnostic technology.One illustrative story of this superpower came during a pivotal moment in Eugene's career. While competing in the XPRIZE competition, he found himself grappling with a flawed prototype. It was during this time, sitting at his wife's bedside after the birth of their child, that the concept for rHEALTH's current device was born. Combining the pressure of the competition, the inspiration of his newborn daughter, and his unwavering focus on creating a robust solution, Eugene developed the technology that would later achieve success in space.Eugene also shared actionable tips for developing this superpower:Identify your personal North Star—a goal or mission that deeply resonates with you.Let that North Star guide your decisions, especially during challenging times.Stay committed to your mission, even when facing setbacks or obstacles.Use external pressures, like deadlines or competitions, to fuel innovation and progress.By following Eugene's example and advice, you can make staying focused on a North Star a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileEugene Chan (he/him):CEO, Founder, rHEALTHAbout rHEALTH: rHEALTH has worked with NASA to develop a miniaturized diagnostic test system to keep astronauts healthy on the way to Mars. We have successfully tested this onboard the International Space Station and published the results in Nature Communications, demonstrating results from blood in minutes in extreme environments. The technology shrinks a central clinical lab and a team of doctors in a form suitable for everyday use. Comprehensive lab-quality analysis can be performed by anyone, fundamentally shifting diagnostics from centralized facilities to the point-of-care and homes. The focus is to usher in Diagnostics 2.0, allowing high-value multiplexed diagnostics.Website: rhealth.comOther URL: startengine.com/offering/rhealthBiographical Information: Dr. Chan is a physician-inventor. He is currently Founder, CEO of rHEALTH, and President, CSO of DNA Medicine Institute, a medical innovation laboratory. He has been honored as Esquire magazine's Best and Brightest, one of MIT Technology Review's Top 100 Innovators, and an XPRIZE winner. His work has contributed to the birth of next-generation sequencing, health monitoring in remote environments, and therapeutics. Dr. Chan holds over 60 patents and publications, with work funded by the NIH, NASA, and USAF. Dr. Chan received an A.B. in Biochemical Sciences from Harvard College summa cum laude in 1996, received an M.D. from Harvard Medical School with honors in 2007, and trained in medicine at the Brigham and Women's Hospital. He has been in zero gravity and led the team that demonstrated the rHEALTH ONE bioanalyzer onboard the International Space Station.LinkedIn Profile: linkedin.com/in/eugene-chan-4220045Personal Twitter Handle: @Dr_EugeneChanSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include Crowdfunding Made Simple. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don't miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year. Learn more about sponsoring the event here. Interested in speaking? Apply here. Support our work with a tax-deductible donation here.SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on January 27th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We'll send private emails to Impact Members with registration details.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.Join C-AR Annual Reporting: Requirements, Deadlines, and Lessons Learned from the Field on January 14, 2026, an informative online webinar designed to help crowdfunding issuers and professionals clearly understand C-AR annual reporting requirements, key deadlines, and real-world insights to stay compliant and prepared.Join UGLY TALK: Women Tech Founders in San Francisco on January 29, 2026, an energizing in-person gathering of 100 women founders focused on funding strategies and discovering SuperCrowd as a powerful alternative for raising capital.If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.Manage the volume of emails you receive from us by clicking here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss 2026 trends. Together, they explore:  JP Morgan Healthcare Conference (00:34): Dr. Morice shares his top observations and takeaways after attending this year's conference. Artificial intelligence (06:02): Anticipated benefits and risks of AI developments predicted in 2026.Reimbursement and regulation (13:43): Why reimbursement and regulation continue to be areas of significant interest in clinical diagnostics. Note: Information in this post was accurate at the time of its posting.ResourcesTransforming laboratory medicine through AI: From promise to practice"Answers From the Lab" podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025"Answers From the Lab" podcast: PAMA Update and Accelerating Research and Development With BioPharma Diagnostics

On this episode Lara and Vyanka talk to Professor Alex Richter from the University of Birmingham all about Precision Diagnostics in Immunology. This is ImmunoTea: Your Immunology Podcast, presented by Dr Lara Dungan and Dr Vyanka Redenbaugh. This is the show where we tell you all about the most exciting research going on in the world of immunology. So grab a cup of tea, sit down and relax and we'll fill you in. Contact us at ImmunoTeaPodcast@gmail.com or @ImmunoTea on twitter. Hosted on Acast. See acast.com/privacy for more information.

Trois diagnostics en quelques mois, une maladie rare et une vie loin de la France.Dans ce premier épisode de Tuile d'Expat', Nelly Funk raconte son parcours avec un diabète cétodépendant, une forme encore méconnue, même de certains professionnels de santé.Diagnostiquée à Londres, elle a dû apprendre à naviguer dans un système médical étranger, faire ses propres recherches et devenir patiente experte pour comprendre ce que son corps vivait réellement.Un témoignage intime et éclairant sur le diabète, le poids des étiquettes médicales, la nécessité de s'informer et la réalité du quotidien avec une maladie chronique quand on est expatriée.Les ressources dont Nelly parle dans les épisodes sont les suivantes :Le compte insta de Diabetic Doctor : https://www.instagram.com/temidiabeticdoctor?igsh=eHV4a2FwMzlhbTZhLe compte insta insuleoin : https://www.instagram.com/insuleoin?igsh=MWZzeThnMWg3MmV0Zg==Le compte insta de Mathew L Carter : https://www.instagram.com/mathewlcarter?igsh=ZWxzZTFhZm9xM2p6Une mini-série rendue possible grâce au soutien de la CFE.French Expat est un podcast de French Morning qui raconte les parcours de vie des Français établis hors de France. Retrouvez-le sur toutes les plateformes d'écoute : Spotify, Apple Podcast, Deezer, Google Podcast, Podcast Addict, Amazon Music. Cet épisode est raconté, produit et réalisé par Anne-Fleur Andrle, habillé et mixé par Alice Krief. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

The Impact of Gaze and Fatigue on Medical Decision-Making with Dr. Bulat IbragimovIn this episode of The Girl Doc Survival Guide, Christine interviews Dr. Bulat Ibragimov, an Associate Professor of Machine Learning and Medical Imaging at the University of Copenhagen. Dr. Ibragimov shares personal anecdotes and discusses his research on the role of artificial intelligence and eye tracking in medical decision-making. Key topics include the impact of gaze patterns and fatigue on diagnostic accuracy, the potential for AI to recognize when doctors may make errors, and how individualized gaze patterns can indicate the level of expertise and certainty in medical professionals. The conversation explores the implications of this research for improving the integration of AI in medical practices and enhancing training and decision-making processes for healthcare professionals.00:00 Introduction and Guest Introduction00:49 Personal Anecdote and Background01:46 Eye Tracking and Medical Decision Making03:18 Patterns in Gaze and Error Prediction11:00 Fatigue and Its Impact on Accuracy16:09 AI and Gaze Analysis in Medical Training20:07 Conclusion and Final Thoughts

Lauren Rosenberg, a highly experienced Physician Associate, has dedicated nearly two decades to Internal Medicine and Health Optimization. Driven by a passion for preventative care, Lauren founded Vent Health to shift the focus from disease treatment to prevention. She specializes in a personalized approach that blends genetics, epigenetics, biomarkers, and lifestyle factors to tailor health interventions that extend and optimize each patient's healthspan. Lauren's practice includes prescribing peptides (GLP, CLP/GIP) for weight loss, insulin resistance, pre-diabetes, etc. This episode concentrates on all the questions about GLP's, the prescription based Ozempic and others, as well as the Compound Pharmacy GLP's that can often times be less expensive. Heather and Lauren also cover the common side effects, and how to manage them. In this episode you will learn other health benefits of these peptides, and who can benefit from them as well as practical tips for getting started on GLP-1 Therapy. Lauren is a frequent speaker at the Age Management Medicine Group (AMMG) and the American Academy of Anti-Aging Medicine (A4M) conferences. Lauren's practice includes Cardiology prevention: Diagnostics and AI analysis to detect dangerous plaque and calcium; advanced lipid testing and cardiovascular genetics Longevity biomarkers: DNA methylation for biological age, VO2 max testing, Telomere health; Therapeutic plasma exchange Cancer prevention: methylated DNA screens, preventative MRIs, tumor marker testing. We will have Lauren back to discuss all these other longevity and optimum health subjects. This episode concentrates on the information pertaining to Peptides, GLP's etc as they are so popular right now. If you want to contact Lauren for more info, you can reach her via her site: https://myventhealth.com and go to the contact page. Or email: vent@myventhealth.com Website: www.heatherthomson.com Social Media: IG: https://www.instagram.com/iamheathert/ You Tube: https://youtube.com/@iamheathert?si=ZvI9l0bhLfTR-qdo Learn more about your ad choices. Visit megaphone.fm/adchoices

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com At-home blood testing is moving diagnostics out of clinics and into people's lives, removing friction while expanding access to critical health insights. In this episode, Michael Dubrovsky, co-founder and CEO of SiPhox Health, discusses how his team is reimagining blood testing through painless at-home collection and advanced diagnostics focused on longevity and overlooked biomarkers. He explains why traditional blood testing in the U.S. is burdened by complexity, how SiPhox fills gaps left by primary care, and the growing consumer demand for deeper health data. Michael shares the origins of the company's silicon photonics technology, the challenges of clinician trust and FDA clearance, and how home testing is already saving lives by identifying conditions like heart disease and hemochromatosis earlier. He also explores B2B use cases, funnel optimization, health equity, and why betting on fully home-based testing is a bold but necessary move for the future of healthcare. Tune in and learn how at-home diagnostics could fundamentally change how care is delivered and experienced! Resources: Connect with and follow Michael Dubrovsky on LinkedIn. Follow SiPhox Health on LinkedIn and visit their website! Listen to Michael's podcast on Apple Podcasts or Spotify. Email Michael directly here.

How do veterinary diagnostics and education combine to advance veterinary medicine? Tails From the Lab podcast host Dr. Holly Brown sits down to discuss clinical education, diagnostics, and more with Dr. Jimmy Barr (DVM, DACVECC), Chief Medical Officer at Antech™ and Mars Science & Diagnostics, and Dr. Michelle Evason (BSc, DVM, DACVIM, MRCVS), Director of Veterinary Education & Outreach at Antech. Antech & VETgirl are transforming veterinary care through innovative educational programs, like the annual VETgirl certificate series, designed to empower veterinarians, technicians, nurses and teams with practical, pet-first, options-based education. From dentistry to contextualized diagnostics and imaging to infectious diseases, this program includes timely information to advance your preventive care practice. Tune in to hear insights on the upcoming 2026 program, the importance of contextualized diagnostics, and how Antech's initiatives are shaping the future of veterinary practice—all while making complex science accessible and actionable for those on the front lines of animal health. Interested in the 2026 VETgirl Preventive Care Certificate? Earn this certificate for free until 12/31/26, complimentary from Antech. Tails from the Lab is a production of Antech Diagnostics™. The intent of this podcast is to provide education and guidance with the understanding that any diagnostic testing and treatment decisions are ultimately at the discretion of the attending veterinarian within the established veterinarian-patient-client relationship.

How do you go from managing a gym to managing trauma cases in the Operating Room?In this episode, we sit down with Roo Cotter, a former personal trainer who made the incredible leap into the high-stakes world of medical device sales. Roo shares her journey of getting recruited by a gym member to work for Stryker Trauma, navigating the chaos of 14-hour days in the O.R., and her recent pivot into the innovative field of cancer diagnostics with Exact Sciences.If you are an athlete, a trainer, or someone looking to break into medical sales but don't know where to start, this conversation is for you. Roo breaks down how she used grit, networking, and the Medical Sales U program to land her dream job in under two months.IN THIS EPISODE, YOU WILL LEARN:- The unlikely path: How working hard at a gym led to a "lucky" break in MedTech.- The reality of Trauma: What it's really like to be on call 24/7 (and why it teaches you resilience).- Ortho vs. Diagnostics: Why Roo transitioned from the "meathead" world of orthopedics to early cancer detection.- Networking Hacks: How to get internal referrals and skip the "ghosting" phase of job applications.- Mental Toughness: Balancing a high-pressure career with the "1000 Hours Outside" challenge.CHAPTERS:0:00 - Intro: From Personal Trainer to the O.R. 1:55 - Why a Finance Major chose Fitness2:45 - Building relationships with doctors at the gym5:40 - Getting scouted: The Story of landing the Stryker job8:37 - The harsh reality of Trauma Sales (and 14-hour days)13:25 - Transitioning to Neuromodulation (Nalu Medical)16:00 - The Pivot to Diagnostics: Joining Exact Sciences19:15 - How Medical Sales U helped speed up the process24:00 - Avoiding Burnout: The "1000 Hours Outside" ChallengeREADY TO BREAK INTO MEDICAL SALES? If you want to fast-track your career like Roo did, check out our program. We help professionals transition into top-tier medical sales roles: medicalsalesu.com/About the Guest: Roo Cotter is a Medical Sales Professional with experience in Trauma, Neuromodulation, and Diagnostics. A Miami University graduate, she combines her background in finance and fitness to bring a unique, disciplined approach to the O.R.#MedicalSales #Stryker #CareerPivot #PersonalTrainer #MedicalDeviceSales #ExactSciences #SalesCoaching #CareerAdvice #OrthoDisclaimer: The views expressed in this video are those of the participants and do not necessarily reflect the official policy or position of any other agency, organization, employer, or company.

Get a first look at Antech's VMX 2026 education program — built around the realities of clinical practice and the growing need to apply contextualized diagnostics . Join Dr. Michelle Evason (BSc, DVM, DACVIM, MRCVS), Director of Education & Outreach at Antech, and Tammi Lesser, LVT, Regional President, Mars Science & Diagnostics, North America for a behind-the-scenes preview of this year's key themes, including preventive care, case-based learning, and what's new in diagnostic innovation. You'll hear how topics like GI parasite testing, vector-borne disease, and imaging are being brought to life through practical case examples. Plus, gain insight into how veterinary teams can better connect diagnostics to decision-making, communication, and everyday workflow. Tails from the Lab is a production of Antech Diagnostics. The intent of this podcast is to provide education and guidance with the understanding that any diagnostic testing and treatment decisions are ultimately at the discretion of the attending veterinarian within the established veterinarian-patient-client relationship.Just a quick note before we jump into today's episode. Our guests today are Tammi Lesser and Michelle Evason who are employed by Antech. We're sharing this so you have full transparency about the relationships involved.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/MDY865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Implementing Innovation in Alzheimer's Care: Practical Approaches to Adopting New Diagnostics and Disease-Modifying Treatments In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/MDY865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Implementing Innovation in Alzheimer's Care: Practical Approaches to Adopting New Diagnostics and Disease-Modifying Treatments In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss direct-to-consumer testing. Then, Dr. Pritt welcomes Matthew Binnicker, Ph.D., a microbiologist and virologist and chief scientific officer of Mayo Clinic Laboratories, for a conversation about accelerating innovation without compromising quality or safety. Direct-to-consumer testing (00:38): Explore the rise of direct-to-consumer testing and the challenges that accompany it. Evolving expectations for innovation (05:38): Understand why patient and clinician expectations are rising and how that is reshaping diagnostics.Safeguarding advances (07:23): Learn the foundational principles that protect quality and safety amid rapid innovation.Strategies for accelerating innovation (10:33): Discover practical ways to responsibly deliver novel solutions more quickly.Note: Information in this post was accurate at the time of its posting.ResourcesFive ways to move faster without compromising trust in diagnostics"Answers From the Lab” podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025360Dx: 2025 highlights and takeaways for the clinical lab industry

Most sales teams don't struggle from lack of leads. They struggle from a lack of qualified leads. In this episode of the CEO Sales Strategies Podcast, Doug C. Brown speaks with Maeve Ferguson—founder of The Client Engine™—about how score-based diagnostics and AI segmentation are revolutionizing the way we qualify B2B buyers. Whether you're leading an enterprise sales team or scaling a high-ticket consulting offer, this episode will help you: ✅ Understand why forms and funnels fail to qualify ✅ Use diagnostics to separate low vs. high-intent buyers ✅ Align sales and marketing on what a real lead looks like ✅ Increase revenue per rep by improving qualification

About Michael Dubrovsky:Michael Dubrovsky is a founder-operator and applied scientist working at the intersection of materials science, photonics, and real-world impact. He is the co-founder and CEO of SiPhox Health, a Y Combinator (S20), Khosla Ventures, and Intel Capital–backed startup based in Cambridge, building painless at-home blood biomarker testing to help people live healthier, longer lives. Alongside SiPhox, he serves on the Clinical and Laboratory Standards Institute (CLSI) ILA20 committee and co-hosts 632nm, a technical interview series featuring top scientists and engineers. Previously, he co-founded PoWx, a nonprofit advancing energy-efficient photonic hardware for proof-of-work cryptography, work that is now used commercially to secure billions of dollars in value. Earlier in his career, Michael founded Simply Grid, named by Fast Company as one of the world's most innovative energy companies, deploying first-of-its-kind curbside EV and food-vendor charging infrastructure in New York City before exiting via acquisition. His background includes advanced research at MIT and Technion in nanofabrication and materials characterization and a BS in Chemistry from SUNY ESF. His personal mantra: no hurry, no pause.Things You'll Learn:At-home blood testing eliminates major barriers, such as appointments, referrals, and travel, while expanding access to advanced diagnostics. This convenience is driving higher adoption among both consumers and businesses.Many critical biomarkers linked to longevity and chronic disease are often ignored in standard primary care testing. Home testing allows patients to proactively monitor what would otherwise go unseen.Clinician trust remains a challenge due to early inaccuracies in home testing technologies. FDA clearance is expected to play a major role in broader medical acceptanceBusinesses benefit from home testing by eliminating high-friction steps that stall patient conversion. This leads to better experiences and significantly improved funnel performance.Scaling home diagnostics follows a familiar pattern where early adopters subsidize innovation. Over time, costs drop and access expands to broader populations.Resources:Connect with and follow Michael Dubrovsky on LinkedIn.Follow SiPhox Health on LinkedIn and visit their website.Listen to Michael's podcast on Apple Podcasts or Spotify.Email Michael directly here.

Like the show? Show your support by using our sponsors. Promotive can help you find your dream job. Touch HERE to see open jobs. Need to update your shop systems and software? Try Tekmetric HERERegister NOW for Tekmetric's Tektonic Conference coming up HEREIn this episode, Jeff Compton sits down with Bob Leonard from Mobility Works to delve into the specialized world of vehicle modifications for people with physical disabilities. Bob shares insights into the unique regulatory landscape and technical requirements affecting mobility vehicle conversions, including the importance of following strict certification rules and working closely with certified evaluators. The conversation highlights the technician shortage in the mobility industry, the blend of mechanical and electrical skills required, and the impactful difference these vehicles make in the lives of customers.Timestamps: 00:00 Introduction to The Jaded Mechanic 00:40 Live at ASTA 2025: Meet Bob Leonard from Mobility Works 01:59 What is Mobility Works? The Mission and Services Explained 03:13 Types of Modifications: Minivans, Hand Controls, and High-Tech Installs 05:58 Certification and Audit Processes in Mobility Vehicle Service 08:46 Repairing or Correcting Others' Work: Challenges in Mobility Vehicle Service 11:22 Prescriptions, Regulations & Working with Certified Evaluators 14:19 How Modifications Affect Standard Vehicle Repairs 16:35 Diagnosing Issues When Factory Systems and Modified Controls Meet 19:06 Adapting to EVs and Hybrids in the Mobility Industry 22:04 The Human Side: Fittings, Customer Stories & Building Trust 25:48 Technician Shortages & The Specialized Skills Required 29:08 Training, Following Procedures, and the Role of Inspections 32:38 Troubleshooting Wiring, Diagnostics, and Common Mistakes 36:58 Customer Impact: Independence, Freedom, and Lasting Relationships 41:12 Insurance, Rentals, and the Cost of Mobility Vehicle Ownership 45:42 Body Shop Challenges: Repairs, Estimating, and Crash-Tested Parts 51:02 Advice for Technicians: Approach, Caution, and Knowing When to Call Experts 54:59 The Growing Mobility Market & Emerging Trends 57:01 Life-Changing Mobility Solutions: Why This Work Matters 01:02:57 Wrap-Up: Spreading Awareness & Educating Technicians Follow/Subscribe to the show on social media! TikTok - https://www.tiktok.com/@jeffcompton7YouTube - https://www.youtube.com/@TheJadedMechanicFacebook - https://www.facebook.com/profile.php?id=100091347564232

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Accessible diagnostics isn't a luxury anymore; it's the missing link preventing millions from receiving timely care. In this episode, James York, Chief Commercial Officer and Head of Government Affairs for Molecular Testing Labs, discusses how reimagining the patient journey can remove the economic, geographic, and emotional barriers that keep people from getting essential tests. He explains how at-home self-collection, transparent pricing, and frictionless access are transforming diagnostics, especially for conditions like HIV, STIs, chronic disease markers, and wellness indicators. James walks through the challenges of pioneering new models in healthcare, including regulatory hurdles, industry resistance, and the realities of scaling without major outside funding. He also explains why affordability is inseparable from access, how virtual care has shifted expectations, and why focusing on everyday tests, not cutting-edge technology, is where the greatest impact lies. Tune in and learn how simplifying diagnostics can unlock a more equitable, consumer-centered healthcare system! Resources Connect with and follow James York on LinkedIn. Follow Molecular Testing Labs on LinkedIn and visit their website!

Service Advisors Refusing Walkarounds? Scheduling Chaos? Customers Who Can't Afford Repairs? In this episode of Service Drive Revolution, Chris Collins answers real, unfiltered questions straight from the service drive. From why advisors resist walkarounds, to how to properly schedule service appointments, to what to do when customers can't afford diagnosed repairs, this episode is packed with practical leadership insight and real-world systems thinking. 

Send me a question or story!Periocular dermatitis can occur for a multitude of reasons. The first step is to figure out if the eye itself is involved or not. Once we know the eye is healthy, it is time to figure out why the SKIN AROUND the eye is losing hair, crusty, itchy, etc.It is important to return to the basic diagnostics. Cytology can be sampled with tape (if the lesion is dry) or swab (if the lesion is wet) to not risk damaging the eye. A trichogram can be used instead of a skin scrape to also protect the eye from a scalpel blade!Anything that can cause folliculitis to other areas of the skin can impact the periocular dermatitis. Allergies, mites, dermatophytosis, pyoderma, yeast dermatitis, autoimmune diseases and neoplasia can cause lesions. Dive into the details on this week's episode of The Derm Vet podcast!Timestamps00:00 Intro03:00 Periocular Dermatitis05:21 Cytology Techniques06:45 Allergies and Facial Pruritus08:20 Demodex12:00 Biopsy13:20 Neoplasia16:00 Outro

As part of our official DealFlow Discovery Conference Interview Series, produced by Mission Matters, along with our partner DealFlow Events, we're showcasing the innovative companies presenting at the DealFlow Discovery Conference and the executives behind them. ---- In this episode, Adam Torres interviews Ilan Danieli, CEO of Precipio, about the company's mission to reduce cancer misdiagnosis—especially in complex blood-related cancers. Ilan explains how Precipio partners with academic experts to expand access to subspecialty pathology, why accuracy matters more than speed, and how better diagnostics can directly change treatment decisions and patient outcomes. About Ilan Danieli Ilan Danieli has served as Precipio's CEO since founding the company in early 2011. With over 20 years managing small and medium-size companies, some of his previous experiences include COO of Osiris, a publicly-traded company based in New York City with operations in the US, Canada, Europe; Laurus Capital Management, a multi-billion dollar hedge fund; and in various other entrepreneurial ventures. Ilan holds an MBA from the Darden School at the University of Virginia, and a BA in Economics from Bar-Ilan University in Israel. Ilan has a private pilot license, plays the saxophone, and possesses infinite love for his horses. About Precipio Precipio's platform delivers superior diagnostic accuracy through academic expertise and cutting edge technology. They are a laboratory focused on delivering specialized diagnostic services to physicians and their patients to ensure they receive accurate results. Watch Full Episode on ⁠Youtube⁠. --- This interview is part of our effort to help investors discover compelling companies ahead of the event — and to help CEOs introduce their story to the 1500+ conference attendees. Learn more about the event and presenting companies: ⁠⁠https://dealflowdiscoveryconference.com/⁠ Follow Adam on Instagram at ⁠https://www.instagram.com/askadamtorres/⁠ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: ⁠https://missionmatters.lpages.co/podcastguest/⁠ Visit our website: ⁠https://missionmatters.com/⁠ More FREE content from Mission Matters here: ⁠https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

Start making $150k - $200k+ in your first year of medical sales. Stop chasing crowded "old school" roles like Orthopedics and Spine. The real money—and the life-saving innovation—is in Oncology and Specialty Pharma. Today, I reveal the exact blueprint to reinvent your career and break into the most lucrative sector of healthcare. Whether you're a nurse, a teacher, or stuck in a "middle-class mindset," this episode breaks down why your background doesn't matter. Only your preparation does.I share my personal journey from a non-profit minister making $70k to a high-level oncology rep, and explain why "casual advice" from friends will get you rejected. If you want to master the interview, crush your clinical knowledge, and build a 6-figure life, this is the masterclass you need.WHAT YOU WILL LEARN IN THIS EPISODE:- The "Gold Rush" Shift: Why you should ignore Orthopedics and focus entirely on Oncology, Diagnostics, and Genetic Testing.- The 3 Essential Mindset Shifts: How to move from "winging it" to becoming an obsessively prepared candidate.- Real Success Stories: How Kanika (immigrant to Dallas), Sydney (nurse), and others went from zero experience to $200k roles.- The "Ride-Along" Trap: Why you need a brutal coach, not a nice mentor.- The HEART Framework: The 5 character traits (Humility, Energy, Active Listening, Resilience, Trust) that hiring managers look for.- Confidence vs. Arrogance: How to show "grit" without sounding like a jerk.- Daily Habits of Top 1% Earners: The 5 AM club, the "20 LinkedIn adds" rule, and why your degree (MBA) has a lower ROI than coaching.- The Michael Jordan Rule: Why even the greatest of all time hired coaches for their specific weaknesses.TIMESTAMPS00:00 - Introduction: The Program Focus (Oncology vs. Orthopedics)01:34 - Dave's Story: Reinventing Career from Ministry to Medical Sales03:44 - Success Stories: How Nurses & Immigrants Got Hired (Kanika, Sydney)06:47 - Mindset Shift #1: Be Coachable (Why Friends Can't Help You)09:20 - Mastering Virtual Interviews (Lighting, Camera & Background)10:32 - Mindset Shift #2: Be Curious (Understanding Clinical Trials & FDA)12:32 - Salary Reality: Device Associate ($80k) vs. Oncology ($155k+)13:55 - Mindset Shift #3: Collaboration (Working with MSLs & Nurse Navigators)16:28 - Confidence vs. Arrogance (The "Grit" Trap)18:02 - The H.E.A.R.T. Framework (Humility, Energy, Listening, Resilience, Trust)19:00 - Daily Habits: 5 AM Wake-ups, LinkedIn Strategy & Handling Rejection20:00 - The"Middle Class Mindset" Trap: Why Degrees Have Low ROI22:25 - Using AI for Resumes Without Sounding Like a Robot25:55 - The "Why": Patient Outcomes & Life-Extending Impact29:35 - The 3 Questions You Must Ask Yourself31:01 - The Michael Jordan Analogy: Why Even the Best Hire Coaches.ABOUT MEDICAL SALES U: Medical Sales U is the premier training program for professionals looking to break into high-paying careers in Medical Device, Pharmaceutical, and Genetic Testing sales. We turn "outsiders" into top 1% candidates.CONNECT WITH US: Learn more about coaching and career support at medicalsalesu.com/#MedicalSales #OncologySales #CareerPivot #SalesCoaching #HighIncomeSkills #DaveSterrett #MedicalSalesYou #InterviewTips #SalesJobs #PharmaceuticalSales

Graham Rigby is the President and CEO of the American Herbal Products Association (AHPA), the leading trade association for the herbal products industry. With 20 years of experience across startups and industry leadership—including serving as Chief Innovation Officer at Care/of—Graham has helped shape how modern supplement brands navigate regulation, formulation, and go-to-market strategy.In this episode of DTC Pod, Graham shares what it actually takes to launch and scale a supplement brand without getting burned by regulators. He breaks down exactly where the line is between claims that sell and claims that get you in trouble, why so many founders get blindsided by FDA and FTC enforcement, and how to work with contract manufacturers when you're just starting out. Graham also gets into the real opportunity in supplements right now—why clinical trials cost 90% less than they did two decades ago, how AI is changing the formulation game, and why a $70 billion market growing at 6.5% still has plenty of room for new entrants. Plus, his take on the brands that are doing it right, from AG1 to Ritual, and what founders can learn from their playbooks.Episode brought to you by StordInteract with other DTC experts and access our monthly fireside chats with industry leaders on DTC Pod Slack.On this episode of DTC Pod, we cover:1. The evolution and growth of the herbal supplement industry2. Key regulatory milestones: DSHEA, GMPs, and FDA compliance for supplements3. What founders must do to stay compliant when launching a supplement brand4. The distinction between pharmaceuticals, dietary supplements, and nutraceuticals5. Marketing, claims, and the importance of substantiation6. Emerging opportunities with clinical trials and claim innovation7. DTC, Amazon, TikTok, and brick-and-mortar distribution channels for wellness brands8. The practicalities and risks of supplement retail (and when to scale beyond DTC)9. Practitioner and non-traditional channels for supplement sales10. How Ingredient AI, Infinite Garden, and other platforms are applying AI to supplements11. Content creators, credentialed doctors, and the new face of trusted health advice12. The role of diagnostics, wearables, and personalization in driving supplement trends13. Growth outlook: Why the supplement market is just getting startedTimestamps00:00 Intro to DTC POD and Graham Rigby02:25 20 years of supplements: Startup vs. regulatory side03:00 The exponential growth of the herbal products market04:44 Regulatory basics: DSHEA, FDA oversight, and GMPs explained07:14 How AHPA helps brands navigate compliance and education08:03 Launching a supplement brand: Key compliance steps and best practices10:00 FDA's post-market regulatory process and founder responsibilities13:04 Supplements vs. pharmaceuticals: Safety, claims, and approvals17:32 Telling stories and using clinical research for marketing claims20:00 What marketers can and cannot say: Health vs. disease claims22:04 Substantiating claims and the importance of compliance for growth24:31 Label vs. online claims: How rules apply to different channels27:02 DTC vs. Amazon, TikTok, and expanding to retail and practitioner channels30:19 The risks and rewards of brick-and-mortar expansion35:14 AI and technology's role in supplement industry efficiency and safety40:47 The rise of content creators and doctors shaping supplement education46:34 Diagnostics, wearables, and the future of personalized wellness51:13 Supplement industry outlook and advice for emerging brands52:25 How to connect with Graham and AHPA, and upcoming founder programsShow notes powered by CastmagicPast guests & brands on DTC Pod include Gilt, PopSugar, Glossier, MadeIN, Prose, Bala, P.volve, Ritual, Bite, Oura, Levels, General Mills, Mid Day Squares, Prose, Arrae, Olipop, Ghia, Rosaluna, Form, Uncle Studios & many more.  Additional episodes you might like:• #175 Ariel Vaisbort - How OLIPOP Runs Influencer, Community, & Affiliate Growth• #184 Jake Karls, Midday Squares - Turning Your Brand Into The Influencer With Content• #205 Kasey Stewart: Suckerz- - Powering Your Launch With 300 Million Organic Views• #219 JT Barnett: The TikTok Masterclass For Brands• #223 Lauren Kleinman: The PR & Affiliate Marketing Playbook• ​​​​#243 Kian Golzari - Source & Develop Products Like The World's Best Brands-----Have any questions about the show or topics you'd like us to explore further?Shoot us a DM; we'd love to hear from you.Want the weekly TL;DR of tips delivered to your mailbox?Check out our newsletter here.Projects the DTC Pod team is working on:DTCetc - all our favorite brands on the internetOlivea - the extra virgin olive oil & hydroxytyrosol supplementCastmagic - AI Workspace for ContentFollow us for content, clips, giveaways, & updates!DTCPod InstagramDTCPod TwitterDTCPod TikTokGraham Rigby - President & CEO of American Herbal Products Association (AHPA)Blaine Bolus - Co-Founder of CastmagicRamon Berrios - Co-Founder of Castmagic

Mike Nemer interviewed Kevin Carriere, the CEO of Powertron Global, who explained that he entered the HVAC industry after meeting engineers developing solutions for heat exchanger efficiency restoration. On episode 310 of The Green Insider podcast, Kevin described how Powertron Global was founded to address HVAC efficiency issues, expanding beyond initial heat exchanger solutions to tackle other efficiency-robbing factors in climate control systems. Todays podcast includes: Sustainable HVAC Efficiency Restoration Sustainable HVAC practices can lead to cost savings, not just environmental benefits. HVAC systems lose efficiency over time, mainly due to heat exchanger capacity loss, which increases energy use and maintenance. Powertron engineers developed a heat exchanger restoration technology to restore lost efficiency, filling a gap in the industry. Craftsmanship and education on efficiency restoration are crucial, especially for city and government agencies. HVAC Efficiency Diagnostics Platform Most HVAC systems, especially in taxpayer-funded facilities, operate 30–40% below their intended design capacity. Powertron created a proprietary forensic measurement and verification platform, collecting data from over 400 studies in 38 countries. The company focuses on restoring system capacity and providing diagnostic data to manufacturers and researchers, serving clients like cell tower huts, convenience stores, and government facilities. HVAC Efficiency Loss Over Time New HVAC systems lose 5–7% efficiency in the first year (with proper maintenance), then 3–4% annually, reaching a 25–30% reduction over time. Systems in regions with long cooling seasons (eastern/western US) can lose significant efficiency in 3.5–5 years; in the Midwest, it takes about twice as long. Rooftop units expected to last 15 years are often replaced in 10 due to efficiency loss and increased runtime. Type System ROI and Sustainability The ROI for Powertron's type system is typically 12–18 months, but as short as 3 months for mission-critical sites (e.g., data centers, hospitals). The goal is to restore systems to their design capacity, improving efficiency and generating further savings. Certified reports are provided to quantify emissions reductions and energy savings, which can be used in customers' sustainability reports. To be an Insider Please subscribe to The Green Insider powered by ERENEWABLE wherever you get your podcast from and remember to leave us a five-star rating. This podcast is sponsored by UTSI International. To learn more about our sponsor or ask about being a sponsor, contact ERENEWABLE and the Green Insider Podcast. The post Maximizing HVAC Efficiency: Sustainable Restoration, Diagnostics, and ROI appeared first on eRENEWABLE.

Health care executive Kevin King discusses his article, "How to stay safe from back-to-school illnesses." Kevin explains why the return to classrooms often triggers a surge in respiratory illnesses (like the flu, COVID-19, and RSV) and how diagnostic tests are a critical tool for managing them. He highlights how rapid diagnostics are essential for getting the right treatment quickly, such as antivirals, and perhaps more importantly, for preventing the wrong treatment, which helps combat the growing threat of antibiotic resistance. Kevin also offers insight into how epidemiologists predict outbreaks by monitoring school absenteeism and data from the Southern Hemisphere, providing a fascinating look at community health surveillance. Discover how early and accurate testing serves as our frontline defense in protecting vulnerable populations and managing respiratory illnesses this school season. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended